Scholars Central

PerspectivePublished 31 Jan 2022

Therapeutic Application of rTMS in Atypical Parkinsonian Disorders

Authors: Sherlyn Cullen

Journal of Neurology and Clinical Neuroscience

Volume 6 · Issue 1 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and dementia with Lewy bodies are the four principal forms of sporadic neuronal multisystem degeneration that are referred to as atypical parkinsonian disorders (APDs) and Parkinson plus syndromes (LBD). APDs are characterised by a wide range of symptoms and a paucity of disease-modifying medications; as a result, symptomatic therapy is the norm. Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive and safe brain stimulation technique that uses a magnetic coil and is used to treat a variety of neuropsychiatric disorders. In this work, we evaluate the research on the efficacy of repetitive transcranial magnetic stimulation (rTMS) in the treatment of various APDs and Parkinson+syndromes. The majority of research has found that it helps with both motor and nonmotor symptoms.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Neurology and Clinical Neuroscience
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Sherlyn Cullen”